Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 274 articles:
HTML format
Text format



Single Articles


    July 2017

  1. Fischer K, Al-Sawaf O, Fink A-M, et al. Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood. 2017;129(19):2702-2705.
    Blood. 2017;130:232.
    PubMed     Text format    


  2. THAKRAL B, Muzzafar T
    Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
    Blood. 2017;130:231.
    PubMed     Text format    


  3. TALSMA CE, Boyer DF
    Myeloid leukemia associated with Down syndrome.
    Blood. 2017;130:230.
    PubMed     Text format    


  4. SCHEWE DM, Alsadeq A, Sattler C, Lenk L, et al
    An Fc engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts.
    Blood. 2017 Jul 11. pii: blood-2017-01-764316. doi: 10.1182/blood-2017-01-764316
    PubMed     Text format     Abstract available


  5. CARPENTER PA, Johnston L, Fernandez HF, Radich JP, et al
    Post-transplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.
    Blood. 2017 Jul 11. pii: blood-2017-03-771121. doi: 10.1182/blood-2017-03-771121
    PubMed     Text format    


    June 2017
  6. QUESADA AE, Kanagal-Shamanna R
    Targeted therapy-induced differentiation of acute myeloid leukemia blasts.
    Blood. 2017;129:3503.
    PubMed     Text format    


  7. MORIYAMA T, Yang YL, Nishii R, Ariffin H, et al
    Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry.
    Blood. 2017 Jun 28. pii: blood-2017-05-782383. doi: 10.1182/blood-2017-05-782383
    PubMed     Text format     Abstract available


  8. NARITA T, Ishida T, Ito A, Masaki A, et al
    Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
    Blood. 2017 Jun 23. pii: blood-2016-09-741983. doi: 10.1182/blood-2016-09-741983
    PubMed     Text format     Abstract available


  9. BRIERLEY CK, Eyre TA
    Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
    Blood. 2017;129:3396.
    PubMed     Text format    


  10. GRIBBEN JG
    Restoring leukemia cell function from the inside out.
    Blood. 2017;129:3137-3138.
    PubMed     Text format    


  11. PROKOCIMER M, Molchadsky A, Rotter V
    Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic work-up and therapy.
    Blood. 2017 Jun 12. pii: blood-2017-02-763086. doi: 10.1182/blood-2017-02-763086
    PubMed     Text format     Abstract available


  12. PRIETO D, Sotelo N, Seija N, Sernbo S, et al
    S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-kappaB activity during disease progression.
    Blood. 2017 Jun 8. pii: blood-2017-02-769851. doi: 10.1182/blood-2017-02-769851.
    PubMed     Text format     Abstract available


  13. STEIN EM, DiNardo CD, Pollyea DA, Fathi AT, et al
    Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia.
    Blood. 2017 Jun 6. pii: blood-2017-04-779405. doi: 10.1182/blood-2017-04-779405.
    PubMed     Text format     Abstract available


  14. AMATANGELO MD, Quek L, Shih A, Stein EM, et al
    Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.
    Blood. 2017 Jun 6. pii: blood-2017-04-779447. doi: 10.1182/blood-2017-04-779447.
    PubMed     Text format     Abstract available


  15. LOCATELLI F, Merli P, Pagliara D, Li Pira G, et al
    Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion.
    Blood. 2017 Jun 6. pii: blood-2017-04-779769. doi: 10.1182/blood-2017-04-779769.
    PubMed     Text format     Abstract available


  16. CHELONI G, Tanturli M, Tusa I, DeSouza NH, et al
    Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
    Blood. 2017 Jun 2. pii: blood-2016-10-745588. doi: 10.1182/blood-2016-10-745588.
    PubMed     Text format     Abstract available


  17. SOLARY E, Itzykson R
    How I treat chronic myelomonocytic leukemia.
    Blood. 2017 Jun 1. pii: blood-2017-04-736421. doi: 10.1182/blood-2017-04-736421.
    PubMed     Text format     Abstract available


    May 2017
  18. MUNCH V, Trentin L, Herzig J, Demir S, et al
    Central Nervous System Involvement in Acute Lymphoblastic Leukemia Is Mediated by Vascular Endothelial Growth Factor.
    Blood. 2017 May 26. pii: blood-2017-03-769315. doi: 10.1182/blood-2017-03-769315
    PubMed     Text format     Abstract available


  19. KATSUYA H, Shimokawa M, Ishitsuka K, Kawai K, et al
    A prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.
    Blood. 2017 May 17. pii: blood-2017-01-757542. doi: 10.1182/blood-2017-01-757542
    PubMed     Text format     Abstract available


  20. CHEN TL, Tran M, Lakshmanan A, Harrington BK, et al
    NF-kappaB p50 (nfkb1) contributes to pathogenesis in the Emu-TCL1 mouse model of chronic lymphocytic leukemia.
    Blood. 2017 May 17. pii: blood-2017-01-761130. doi: 10.1182/blood-2017-01-761130
    PubMed     Text format    


  21. SMITH CC, Paguirigan A, Jeschke GR, Lin KC, et al
    Heterogeneous resistance to quizartinib in acute myeloid leukemia (AML) revealed by single cell analysis.
    Blood. 2017 May 10. pii: blood-2016-04-711820. doi: 10.1182/blood-2016-04-711820
    PubMed     Text format     Abstract available


  22. XU J, Li S
    Triple-hit blastoid mantle cell lymphoma presenting like acute leukemia.
    Blood. 2017;129:2593.
    PubMed     Text format    


  23. GORINI F, Azzimonti L, Delfanti G, Scarfo L, et al
    Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
    Blood. 2017 May 2. pii: blood-2016-11-751065. doi: 10.1182/blood-2016-11-751065.
    PubMed     Text format     Abstract available


    April 2017
  24. KRUTH K, Fang M, Shelton DN, Abu-Halawa O, et al
    Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
    Blood. 2017 Apr 19. pii: blood-2017-02-766204. doi: 10.1182/blood-2017-02-766204
    PubMed     Text format     Abstract available


  25. DING W, LaPlant BR, Call TG, Parikh SA, et al
    Pembrolizumab in patients with chronic lymphocytic leukemia with Richter's transformation and relapsed CLL.
    Blood. 2017 Apr 19. pii: blood-2017-02-765685. doi: 10.1182/blood-2017-02-765685
    PubMed     Text format     Abstract available


  26. VUJKOVIC M, Attiyeh EF, Ries RE, Goodman EK, et al
    Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
    Blood. 2017 Apr 14. pii: blood-2017-03-772384. doi: 10.1182/blood-2017-03-772384
    PubMed     Text format     Abstract available


  27. GARDNER RA, Finney O, Annesley C, Brakke H, et al
    Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults.
    Blood. 2017 Apr 13. pii: blood-2017-02-769208. doi: 10.1182/blood-2017-02-769208
    PubMed     Text format     Abstract available


  28. HU S, Qian M, Zhang H, Guo Y, et al
    Whole-genome non-coding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations.
    Blood. 2017 Apr 13. pii: blood-2017-03-771162. doi: 10.1182/blood-2017-03-771162
    PubMed     Text format    



  29. Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017;129(9):1134-1142.
    Blood. 2017;129:2204.
    PubMed     Text format    


  30. PORCHER C, Chagraoui H, Kristiansen MS
    SCL/TAL1: a multifaceted regulator from blood development to disease.
    Blood. 2017;129:2051-2060.
    PubMed     Text format     Abstract available


  31. SOOD R, Kamikubo Y, Liu P
    Role of RUNX1 in hematological malignancies.
    Blood. 2017;129:2070-2082.
    PubMed     Text format     Abstract available


  32. AVELLINO R, Delwel R
    Expression and regulation of C/EBPalpha in normal myelopoiesis and in malignant transformation.
    Blood. 2017;129:2083-2091.
    PubMed     Text format     Abstract available


  33. DE BRUIJN M, Dzierzak E
    Runx transcription factors in the development and function of the definitive hematopoietic system.
    Blood. 2017;129:2061-2069.
    PubMed     Text format     Abstract available


  34. UFFMANN M, Rasche M, Zimmermann M, von Neuhoff C, et al
    Therapy reduction in patients with Down Syndrome Myeloid Leukemia: The international ML-DS 2006 trial.
    Blood. 2017 Apr 11. pii: blood-2017-01-765057. doi: 10.1182/blood-2017-01-765057
    PubMed     Text format     Abstract available


  35. BELDERBOS ME, Koster T, Ausema B, Jacobs S, et al
    Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
    Blood. 2017 Apr 10. pii: blood-2016-12-758250. doi: 10.1182/blood-2016-12-758250
    PubMed     Text format     Abstract available


  36. TAUB JW, Berman JN, Hitzler JK, Sorrell AD, et al
    Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
    Blood. 2017 Apr 7. pii: blood-2017-01-764324. doi: 10.1182/blood-2017-01-764324.
    PubMed     Text format     Abstract available


    March 2017
  37. GARZON R, Savona M, Baz R, Andreeff M, et al
    A phase I clinical trial of single-agent selinexor in acute myeloid leukemia.
    Blood. 2017 Mar 23. pii: blood-2016-11-750158. doi: 10.1182/blood-2016-11-750158
    PubMed     Text format     Abstract available


  38. FISCHER K, Al-Sawaf O, Fink AM, Dixon M, et al
    Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
    Blood. 2017 Mar 21. pii: blood-2017-01-761973. doi: 10.1182/blood-2017-01-761973
    PubMed     Text format    


  39. CHENG CK, Wang AZ, Wong TH, Wan TS, et al
    FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
    Blood. 2017 Mar 17. pii: blood-2017-02-767707. doi: 10.1182/blood-2017-02-767707
    PubMed     Text format    


  40. LOGHAVI S, Khoury JD
    Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence.
    Blood. 2017;129:1563.
    PubMed     Text format    


  41. HEIN N, Cameron DP, Hannan KM, Nguyen NN, et al
    Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.
    Blood. 2017 Mar 10. pii: blood-2016-05-718171. doi: 10.1182/blood-2016-05-718171
    PubMed     Text format     Abstract available


  42. RAHMAN S, Magnussen M, Leon TE, Farah N, et al
    Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
    Blood. 2017 Mar 7. pii: blood-2016-09-742148. doi: 10.1182/blood-2016-09-742148.
    PubMed     Text format     Abstract available


  43. LAL R, Lind K, Heitzer E, Ulz P, et al
    Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.
    Blood. 2017 Mar 3. pii: blood-2016-11-751008. doi: 10.1182/blood-2016-11-751008.
    PubMed     Text format    


    February 2017
  44. TASIAN SK, Kenderian SS, Shen F, Ruella M, et al
    Optimized Depletion of Chimeric Antigen Receptor T-Cells in Murine Xenograft Models of Human Acute Myeloid Leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-08-736041. doi: 10.1182/blood-2016-08-736041
    PubMed     Text format     Abstract available


  45. MONTALBAN-BRAVO G, Benton CB, Wang SA, Ravandi F, et al
    Greater than one TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-11-749903. doi: 10.1182/blood-2016-11-749903
    PubMed     Text format    


  46. DANESHBOD Y, Medeiros LJ
    Dermal myeloid sarcoma as an initial presentation of acute myeloid leukemia.
    Blood. 2017;129:1056.
    PubMed     Text format    


  47. NAUDIN C, Hattabi A, Michelet F, Miri-Nezhad A, et al
    PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
    Blood. 2017 Feb 23. pii: blood-2016-10-747436. doi: 10.1182/blood-2016-10-747436
    PubMed     Text format     Abstract available


  48. YOSHIZATO T, Nannya Y, Atsuta Y, Shiozawa Y, et al
    Impact of genetic alterations in stem-cell transplantation for myelodysplasia and secondary acute myeloid leukemia.
    Blood. 2017 Feb 21. pii: blood-2016-12-754796. doi: 10.1182/blood-2016-12-754796
    PubMed     Text format     Abstract available


  49. NAKATA Y, Ueda T, Nagamachi A, Yamasaki N, et al
    Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.
    Blood. 2017 Feb 16. pii: blood-2016-06-724658. doi: 10.1182/blood-2016-06-724658
    PubMed     Text format     Abstract available


  50. MILNE TA
    Mouse models of MLL leukemia: recapitulating the human disease.
    Blood. 2017 Feb 8. pii: blood-2016-10-691428. doi: 10.1182/blood-2016-10-691428.
    PubMed     Text format     Abstract available


  51. CAMPANA D, Pui CH
    Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Blood. 2017 Feb 6. pii: blood-2016-12-725804. doi: 10.1182/blood-2016-12-725804.
    PubMed     Text format    


  52. THOMAS D, Majeti R
    Biology and relevance of human acute myeloid leukemia stem cells.
    Blood. 2017 Feb 3. pii: blood-2016-10-696054. doi: 10.1182/blood-2016-10-696054.
    PubMed     Text format     Abstract available


  53. HOLYOAKE TL, Vetrie D
    The chronic myeloid leukemia stem cell: stemming the tide of persistence.
    Blood. 2017 Feb 3. pii: blood-2016-09-696013. doi: 10.1182/blood-2016-09-696013.
    PubMed     Text format     Abstract available


  54. POLLYEA DA, Jordan CT
    Therapeutic targeting of acute myeloid leukemia stem cells.
    Blood. 2017 Feb 3. pii: blood-2016-10-696039. doi: 10.1182/blood-2016-10-696039.
    PubMed     Text format     Abstract available


  55. GODWIN CD, McDonald GB, Walter RB
    Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.
    Blood. 2017 Feb 2. pii: blood-2017-01-762419. doi: 10.1182/blood-2017-01-762419.
    PubMed     Text format    


    January 2017
  56. ISHIZAWA J, Sugihara E, Kuninaka S, Mogushi K, et al
    FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B cell acute leukemia.
    Blood. 2017 Jan 31. pii: blood-2016-07-726216. doi: 10.1182/blood-2016-07-726216
    PubMed     Text format     Abstract available


  57. LAOUEDJ M, Tardif MR, Gil L, Raquil MA, et al
    S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Blood. 2017 Jan 30. pii: blood-2016-09-738005. doi: 10.1182/blood-2016-09-738005
    PubMed     Text format     Abstract available


  58. XU J, Li S
    Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
    Blood. 2017;129:537.
    PubMed     Text format    


  59. GHIA P, Scarfo L, Perez S, Pathiraja K, et al
    Efficacy and safety of dinaciclib versus ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-10-748210. doi: 10.1182/blood-2016-10-748210
    PubMed     Text format    


  60. PYZER AR, Stroopinsky D, Rajabi H, Washington A, et al
    MUC1 mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-07-730614. doi: 10.1182/blood-2016-07-730614
    PubMed     Text format     Abstract available


  61. BOCHTLER T, Granzow M, Stolzel F, Kunz C, et al
    Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
    Blood. 2017 Jan 24. pii: blood-2016-09-738161. doi: 10.1182/blood-2016-09-738161
    PubMed     Text format     Abstract available


  62. MARKS DI, Rowntree C
    A review of the management of adults with T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-07-692608. doi: 10.1182/blood-2016-07-692608
    PubMed     Text format     Abstract available


  63. SANCHEZ-MARTIN M, Ferrando A
    The NOTCH1-MYC highway towards T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-09-692582. doi: 10.1182/blood-2016-09-692582
    PubMed     Text format     Abstract available


  64. LAMY T, Moignet A, Loughran TP Jr
    LGL leukemia: from pathogenesis to treatment.
    Blood. 2017 Jan 23. pii: blood-2016-08-692590. doi: 10.1182/blood-2016-08-692590
    PubMed     Text format     Abstract available


  65. WATANABE T
    Adult T-cell leukemia (ATL): molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
    Blood. 2017 Jan 23. pii: blood-2016-09-692574. doi: 10.1182/blood-2016-09-692574
    PubMed     Text format     Abstract available


  66. FINCH ER, Tukaramrao DB, Goodfield LL, Quickel MD, et al
    Activation of PPARgamma by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-08-736405. doi: 10.1182/blood-2016-08-736405
    PubMed     Text format     Abstract available


  67. LANOCHA AA, Zdziarska B
    T-cell lymphoblastic leukemia with t(11;22)(q24;q12) and EWSR1 rearrangement.
    Blood. 2017;129:393.
    PubMed     Text format    


  68. DE WITTE T, Bowen D, Robin M, Malcovati L, et al
    Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Blood. 2017 Jan 17. pii: blood-2016-06-724500. doi: 10.1182/blood-2016-06-724500
    PubMed     Text format    


  69. WOYACH JA
    How I manage ibrutinib-refractory chronic lymphocytic leukemia.
    Blood. 2017 Jan 17. pii: blood-2016-09-693598. doi: 10.1182/blood-2016-09-693598
    PubMed     Text format     Abstract available


  70. MANTHA S, Goldman DA, Devlin SM, Lee JW, et al
    Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
    Blood. 2017 Jan 12. pii: blood-2016-10-747170. doi: 10.1182/blood-2016-10-747170
    PubMed     Text format     Abstract available


  71. GANZEL C, Reinus C
    Nerves in bone marrow of newly diagnosed therapy-related acute myeloid leukemia.
    Blood. 2017;129:268.
    PubMed     Text format    


  72. XU Z, Beaulieu Bergeron M
    Near-triploid B lymphoblastic leukemia with Burkitt-like morphology.
    Blood. 2017;129:267.
    PubMed     Text format    


  73. KHATER F, Lajoie M, Langlois S, Healy J, et al
    KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.
    Blood. 2017 Jan 9. pii: blood-2016-10-744219. doi: 10.1182/blood-2016-10-744219.
    PubMed     Text format    


  74. GOOSSENS S, Peirs S, Van Loocke W, Wang J, et al
    Oncogenic ZEB2 activation drives sensitivity towards KDM1A inhibition in T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 9. pii: blood-2016-06-721191. doi: 10.1182/blood-2016-06-721191.
    PubMed     Text format     Abstract available


  75. POURABDOLLAH M, Chang H
    Plasma cell neoplasm with plasmablastic morphology mimicking acute leukemia.
    Blood. 2017;129:132.
    PubMed     Text format    


  76. LIU J, Guo B, Chen Z, Wang N, et al
    miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.
    Blood. 2017 Jan 4. pii: blood-2016-06-721027. doi: 10.1182/blood-2016-06-721027.
    PubMed     Text format     Abstract available


  77. CAO M, Li T, He Z, Wang L, et al
    Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.
    Blood. 2017 Jan 4. pii: blood-2016-09-739334. doi: 10.1182/blood-2016-09-739334.
    PubMed     Text format     Abstract available


  78. AHN IE, Underbayev C, Albitar A, Herman SE, et al
    Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
    Blood. 2017 Jan 3. pii: blood-2016-06-719294. doi: 10.1182/blood-2016-06-719294.
    PubMed     Text format     Abstract available


    December 2016
  79. RAIMBAULT A, Chapuis N
    Plasma cell leukemia revealing a G6PD deficiency.
    Blood. 2016;128:3178.
    PubMed     Text format    



  80. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567-572.
    Blood. 2016;128:3017.
    PubMed     Text format    


  81. KIM E, Hurtz C, Koehrer S, Wang Z, et al
    Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.
    Blood. 2016 Dec 28. pii: blood-2016-06-722900. doi: 10.1182/blood-2016-06-722900
    PubMed     Text format     Abstract available


  82. MAXSON JE, Tyner JW
    Genomics of chronic neutrophilic leukemia.
    Blood. 2016 Dec 27. pii: blood-2016-10-695981. doi: 10.1182/blood-2016-10-695981
    PubMed     Text format     Abstract available



  83. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979;54(3):713-733.
    Blood. 2016;128:2871.
    PubMed     Text format    


  84. ABAZA Y, Kantarjian HM, Garcia-Manero G, Estey E, et al
    Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
    Blood. 2016 Dec 21. pii: blood-2016-09-736686. doi: 10.1182/blood-2016-09-736686
    PubMed     Text format     Abstract available


  85. NISS ARFELT K, Barington L, Benned-Jensen T, Kubale V, et al
    EBI2 overexpression in mice leads to B1 B cell expansion and chronic lymphocytic leukemia-(CLL)-like B cell malignancies.
    Blood. 2016 Dec 21. pii: blood-2016-02-697185. doi: 10.1182/blood-2016-02-697185
    PubMed     Text format     Abstract available


  86. QU Y, Siggens L, Cordeddu L, Gaidzik VI, et al
    Cancer specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemia.
    Blood. 2016 Dec 21. pii: blood-2016-07-726877. doi: 10.1182/blood-2016-07-726877
    PubMed     Text format     Abstract available



  87. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-492.
    Blood. 2016;128:2745.
    PubMed     Text format    


  88. FRANCIS SS, Wallace AD, Wendt GA, Li L, et al
    In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia.
    Blood. 2016 Dec 15. pii: blood-2016-07-723148.
    PubMed     Text format     Abstract available


  89. AUBERGER P, Puissant A
    Autophagy, a key mechanism of oncogenesis and resistance in leukemia.
    Blood. 2016 Dec 12. pii: blood-2016-07-692707.
    PubMed     Text format     Abstract available


  90. POWELL JA, Lewis AC, Zhu W, Toubia J, et al
    Targeting sphingosine kinase 1 induces MCL1 dependent cell death in acute myeloid leukemia.
    Blood. 2016 Dec 12. pii: blood-2016-06-720433.
    PubMed     Text format     Abstract available


  91. REA D, Nicolini FE, Tulliez M, Guilhot F, et al
    Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
    Blood. 2016 Dec 8. pii: blood-2016-09-742205.
    PubMed     Text format     Abstract available


  92. BUNTING MD, Varelias A, Souza-Fonseca-Guimaraes F, Schuster IS, et al
    GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
    Blood. 2016 Dec 7. pii: blood-2016-08-734020.
    PubMed     Text format     Abstract available


  93. JAIN N, Roberts KG, Jabbour E, Patel K, et al
    Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Blood. 2016 Dec 5. pii: blood-2016-07-726588.
    PubMed     Text format     Abstract available


  94. LEONG SR, Sukumaran S, Hristopoulos M, Totpal K, et al
    An anti-CD3 / anti-CLL-1 Bispecific Antibody for the treatment of Acute Myeloid Leukemia.
    Blood. 2016 Dec 1. pii: blood-2016-08-735365.
    PubMed     Text format     Abstract available


    November 2016
  95. SAFAVI S, Paulsson K
    Near-haploid and low hypodiploid acute lymphoblastic leukemia - two distinct subtypes but consistently poor prognosis.
    Blood. 2016 Nov 30. pii: blood-2016-10-743765.
    PubMed     Text format     Abstract available


  96. GREVER MR, Abdel-Wahab O, Andritsos LA, Banerji V, et al
    Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
    Blood. 2016 Nov 30. pii: blood-2016-01-689422.
    PubMed     Text format     Abstract available


  97. THEUNISSEN P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, et al
    Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
    Blood. 2016 Nov 30. pii: blood-2016-07-726307.
    PubMed     Text format     Abstract available


  98. GOTLIB J
    How I treat atypical chronic myeloid leukemia.
    Blood. 2016 Nov 29. pii: blood-2016-08-693630.
    PubMed     Text format     Abstract available



  99. Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood. 2014;123(15):2343-2354.
    Blood. 2016;128:2585.
    PubMed     Text format    


  100. DANESHBOD Y, Medeiros LJ
    Pseudo Chediak-Higashi anomaly in acute monoblastic leukemia.
    Blood. 2016;128:2583.
    PubMed     Text format    


  101. THAKRAL B, Khoury JD
    Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.
    Blood. 2016;128:2475.
    PubMed     Text format    



  102. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511-533.
    Blood. 2016;128:2373.
    PubMed     Text format    


  103. CUI B, Ghia EM, Chen L, Rassenti LZ, et al
    High-level ROR1 associates with accelerated disease-progression in chronic lymphocytic leukemia.
    Blood. 2016 Nov 4. pii: blood-2016-04-712562.
    PubMed     Text format     Abstract available


  104. ZHANG J, Kong G, Rajagopalan A, Lu L, et al
    p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
    Blood. 2016 Nov 4. pii: blood-2016-06-719237.
    PubMed     Text format     Abstract available


  105. GOLDBERG AD, Tallman MS
    Down for the count in acute myeloid leukemia.
    Blood. 2016;128:2195-2197.
    PubMed     Text format    


  106. RYAN CE, Sahaf B, Logan AC, O'Brien S, et al
    Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.
    Blood. 2016 Nov 1. pii: blood-2016-06-715284.
    PubMed     Text format     Abstract available


    October 2016

  107. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.
    Blood. 2016;128:2109.
    PubMed     Text format    


  108. BRAIG F, Brandt A, Goebeler M, Tony HP, et al
    Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking.
    Blood. 2016 Oct 26. pii: blood-2016-05-718395.
    PubMed     Text format     Abstract available


  109. MITANI K, Nagata Y, Sasaki K, Yoshida K, et al
    Somatic mosaicism in chronic myeloid leukemia in remission.
    Blood. 2016 Oct 26. pii: blood-2016-06-723494.
    PubMed     Text format    


  110. TASIAN SK, Teachey DT, Li Y, Shen F, et al
    Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.
    Blood. 2016 Oct 24. pii: blood-2016-05-707653.
    PubMed     Text format     Abstract available



  111. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45(3):321-334.
    Blood. 2016;128:1995.
    PubMed     Text format    


  112. LI H, Mar BG, Zhang H, Puram RV, et al
    The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Blood. 2016 Oct 18. pii: blood-2016-05-714493.
    PubMed     Text format     Abstract available


  113. BOTTONI A, Rizzotto L, Lai TH, Liu C, et al
    Targeting BTK through microRNA in chronic lymphocytic leukemia.
    Blood. 2016 Oct 17. pii: blood-2016-07-727750.
    PubMed     Text format     Abstract available


  114. KIM T, Tyndel MS, Kim HJ, Ahn JS, et al
    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.
    Blood. 2016 Oct 12. pii: blood-2016-04-708560.
    PubMed     Text format     Abstract available


  115. ANTONELLI A, Noort WA, Jaques J, de Boer B, et al
    Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.
    Blood. 2016 Oct 12. pii: blood-2016-05-719021.
    PubMed     Text format     Abstract available


  116. BALL M, List AF, Padron E
    When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
    Blood. 2016 Oct 5. pii: blood-2016-07-692988.
    PubMed     Text format     Abstract available


  117. MANCUSI A, Ruggeri L, Velardi A
    Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.
    Blood. 2016 Oct 3. pii: blood-2016-07-730564.
    PubMed     Text format     Abstract available


  118. ANDERSSON E, Tanahashi T, Sekiguchi N, Gasparini VR, et al
    High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.
    Blood. 2016 Oct 3. pii: blood-2016-06-724856.
    PubMed     Text format    


    September 2016
  119. DAGKLIS A, Demeyer S, De Bie J, Radaelli E, et al
    Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
    Blood. 2016 Sep 30. pii: blood-2016-03-703454.
    PubMed     Text format     Abstract available



  120. Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650.
    Blood. 2016;128:1778.
    PubMed     Text format    


  121. CHIANG MY, Wang Q, Gormley AC, Stein SJ, et al
    High selective pressure for Notch1 mutations that induce Myc in T cell acute lymphoblastic leukemia.
    Blood. 2016 Sep 26. pii: blood-2016-01-692855.
    PubMed     Text format     Abstract available


  122. KAJAL B, Chang H
    Acute myeloid leukemia with myelodysplasia-related changes demonstrating mixed-lineage phenotype.
    Blood. 2016;128:1663.
    PubMed     Text format    


  123. HU Z, Sun T
    Blastic plasmacytoid dendritic cell neoplasm associated with chronic myelomonocytic leukemia.
    Blood. 2016;128:1664.
    PubMed     Text format    


  124. KOTROVA M, Musilova A, Stuchly J, Fiser K, et al
    Distinct bilineal leukemia immunophenotypes are not genetically determined.
    Blood. 2016 Sep 13. pii: blood-2016-07-725861.
    PubMed     Text format    


  125. ZEBISCH A, Lal R, Muller M, Lind K, et al
    Acute myeloid leukemia with TP53 germline mutations.
    Blood. 2016 Sep 12. pii: blood-2016-08-732610.
    PubMed     Text format    


  126. DA CUNHA-BANG C, Christiansen I, Niemann CU
    The International prognostic Index for patients with chronic lymphocytic leukemia (CLL-IPI) applied in a population-based cohort.
    Blood. 2016 Sep 7. pii: blood-2016-07-724740.
    PubMed     Text format    


    August 2016
  127. DRUHAN LJ, McMahon DP, Steuerwald N, Price AE, et al
    Chronic neutrophilic leukemia in a child with a CSF3R T618I germline mutation.
    Blood. 2016 Aug 31. pii: blood-2016-07-730606.
    PubMed     Text format    


  128. FALINI B, Martelli MP, Tiacci E
    BRAF-V600E mutation in hairy cell leukemia: from bench to bedside.
    Blood. 2016 Aug 23. pii: blood-2016-07-418434.
    PubMed     Text format     Abstract available



  129. Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968;32(4):507-523.
    Blood. 2016;128:883.
    PubMed     Text format    


  130. FERREIRA TZ, Sandes AF
    Lymphocytosis, villi, and nucleoli: a variant of hairy cell leukemia.
    Blood. 2016;128:1018.
    PubMed     Text format    


  131. SPEEDY HE, Kinnersley B, Chubb D, Broderick P, et al
    Germline mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Blood. 2016 Aug 15. pii: blood-2016-01-695692.
    PubMed     Text format     Abstract available


  132. SUMITOMO Y, Koya J, Nakazaki K, Kataoka K, et al
    Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia.
    Blood. 2016 Aug 1. pii: blood-2015-12-684696.
    PubMed     Text format     Abstract available


    July 2016

  133. Dameshek W. Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood. 1967;29(4):566-584.
    Blood. 2016;128:465.
    PubMed     Text format    


  134. CAI Q, Jeannet R, Hua WK, Cook GJ, et al
    CBFbeta-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia-initiation in mice.
    Blood. 2016 Jul 21. pii: blood-2016-01-693119.
    PubMed     Text format     Abstract available


  135. HO TC, LaMere M, Stevens BM, Ashton JM, et al
    Evolution of acute myelogenous leukemia stem cell properties following treatment and progression.
    Blood. 2016 Jul 15. pii: blood-2016-02-695312.
    PubMed     Text format     Abstract available


  136. MIYOSHI H, Kiyasu J, Kato T, Yoshida N, et al
    PD-L1 expression on neoplastic or stromal cell is respectively poor or good prognostic factor for adult T-cell leukemia/lymphoma.
    Blood. 2016 Jul 14. pii: blood-2016-02-698936.
    PubMed     Text format     Abstract available


  137. MONTEWIS A, Eveillard M
    Acute myeloid leukemia with erythrophagocytosis indicative of KAT6A rearrangement.
    Blood. 2016;128:314.
    PubMed     Text format    


  138. ZHU H, Hu J, Chen L, Zhou W, et al
    The 12-year follow-up of survival, chronic adverse effects and retention of arsenic in patients with acute promyelocytic leukemia.
    Blood. 2016 Jul 11. pii: blood-2016-02-699439.
    PubMed     Text format    


  139. WOLLESCHAK D, Heidel FH
    Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
    Blood. 2016;128:146.
    PubMed     Text format    


  140. ELENA C, Galli A, Such E, Meggendorfer M, et al
    Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
    Blood. 2016 Jul 6. pii: blood-2016-05-714030.
    PubMed     Text format     Abstract available


    June 2016

  141. Whang J, Frei E III, Tjio JH, Carbone PP, Brecher G. The distribution of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Blood. 1963;22(6):664-673.
    Blood. 2016;127:3295.
    PubMed     Text format    


  142. THOMPSON MP, Waters TM, Kaplan EK, McKillop CN, et al
    Hospital volume and acute myeloid leukemia mortality in Medicare beneficiaries aged 65 and older.
    Blood. 2016 Jun 29. pii: blood-2016-05-716662.
    PubMed     Text format    


  143. LIBOUREL EJ, Klerk CP, van Norden Y, de Maat MP, et al
    Disseminated intravascular coagulation at diagnosis is a strong predictor for both arterial and venous thrombosis in newly diagnosed acute myeloid leukemia.
    Blood. 2016 Jun 28. pii: blood-2016-02-701094.
    PubMed     Text format     Abstract available


  144. RASHIDI A, Walter RB, Tallman MS, Appelbaum FR, et al
    Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.
    Blood. 2016 Jun 27. pii: blood-2016-03-674127.
    PubMed     Text format    


  145. RAU RE, Rodriguez B, Luo M, Jeong M, et al
    DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Blood. 2016 Jun 22. pii: blood-2015-11-684225.
    PubMed     Text format     Abstract available


  146. LEIVA-JUAREZ MM, Ware HH, Kulkarni VV, Zweidler-McKay PA, et al
    Inducible epithelial resistance protects mice against leukemia-associated pneumonia.
    Blood. 2016 Jun 17. pii: blood-2016-03-708511.
    PubMed     Text format     Abstract available


  147. KOSCIUCZUK EM, Saleiro D, Kroczynska B, Beauchamp EM, et al
    Merestinib blocks MNK kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.
    Blood. 2016 Jun 15. pii: blood-2016-02-698704.
    PubMed     Text format     Abstract available


  148. METZELER KH, Herold T, Rothenberg-Thurley M, Amler S, et al
    Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
    Blood. 2016 Jun 10. pii: blood-2016-01-693879.
    PubMed     Text format     Abstract available


  149. GREVER MR
    BRAF inhibitor: targeted therapy in hairy cell leukemia.
    Blood. 2016;127:2784-5.
    PubMed     Text format    


  150. PIYA S, Kornblau SM, Ruvolo VR, Mu H, et al
    Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.
    Blood. 2016 Jun 7. pii: blood-2016-01-692244.
    PubMed     Text format     Abstract available


    May 2016
  151. LAMPSON BL, Kasar SN, Matos TR, Morgan EA, et al
    Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.
    Blood. 2016 May 31. pii: blood-2016-03-707133.
    PubMed     Text format     Abstract available


  152. SHORT NJ, Jabbour E, Sasaki K, Patel K, et al
    Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Blood. 2016 May 27. pii: blood-2016-03-707562.
    PubMed     Text format     Abstract available


  153. THIJSSEN R, Ter Burg J, Garrick B, van Bochove GG, et al
    Dual TORK/DNA-PK inhibition blocks critical signalling pathways in chronic lymphocytic leukemia.
    Blood. 2016 May 27. pii: blood-2016-02-700328.
    PubMed     Text format     Abstract available


  154. OFRAN Y, Tallman MS, Rowe JM
    How I treat acute myeloid leukemia presenting with preexisting comorbidities.
    Blood. 2016 May 27. pii: blood-2016-01-635060.
    PubMed     Text format     Abstract available


  155. THORNE SH
    Virus fuels NK cell killing of leukemia.
    Blood. 2016;127:2509.
    PubMed     Text format    


  156. GUO B, Zhang L, Chiorazzi N, Rothstein TL, et al
    IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
    Blood. 2016 May 25. pii: blood-2015-11-682997.
    PubMed     Text format     Abstract available


  157. ELMAAGACLI AH, Koldehoff M
    Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia.
    Blood. 2016 May 23. pii: blood-2016-04-713644.
    PubMed     Text format    


  158. HANDGRETINGER R, Lang P, Andre MC
    Exploitation of Natural Killer (NK) cells for the treatment of acute leukemia.
    Blood. 2016 May 20. pii: blood-2015-12-629055.
    PubMed     Text format     Abstract available


  159. BAHMANYAR M, Chang H
    Acute myeloid leukemia with myelodysplasia-related changes demonstrating prominent basophilic differentiation.
    Blood. 2016;127:2503.
    PubMed     Text format    


  160. RASHIDI A, Fisher SI
    EBV-associated aggressive natural killer cell leukemia.
    Blood. 2016;127:2502.
    PubMed     Text format    


  161. MOORE EM, Roth CG
    Plasma cell leukemia mimicking acute myeloid leukemia.
    Blood. 2016;127:2359.
    PubMed     Text format    



  162. Heyssel R, Brill AB, Woodbury LA, et al. Leukemia in Hiroshima atomic bomb survivors. Blood. 1960;15(3):313-331.
    Blood. 2016;127:2165.
    PubMed     Text format    


    April 2016
  163. SMALLWOOD DT, Apollonio B, Willimott S, Lezina L, et al
    Extracellular vesicles released by CD40/IL-4 stimulated chronic lymphocytic leukemia cells confer altered functional properties to CD4+ T cells.
    Blood. 2016 Apr 26. pii: blood-2015-11-682377.
    PubMed     Text format     Abstract available


  164. MA HS, Greenblatt SM, Shirley CM, Duffield AS, et al
    All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.
    Blood. 2016 Apr 21. pii: blood-2015-05-646786.
    PubMed     Text format     Abstract available


  165. WILLIAMS MT, Yousafzai YM, Elder A, Rehe K, et al
    The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
    Blood. 2016;127:1998-2006.
    PubMed     Text format     Abstract available


  166. MICHEL G, Galambrun C, Sirvent A, Pochon C, et al
    Single versus double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.
    Blood. 2016 Apr 20. pii: blood-2016-01-694349.
    PubMed     Text format     Abstract available


  167. JOHNSON SM, Dempsey C, Chadwick A, Harrison S, et al
    Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia.
    Blood. 2016 Apr 20. pii: blood-2015-12-688051.
    PubMed     Text format    


  168. PARKER WT, Yeung DT, Yeoman AL, Altamura HK, et al
    The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.
    Blood. 2016;127:1870-80.
    PubMed     Text format     Abstract available


  169. ARBER DA, Orazi A, Hasserjian R, Thiele J, et al
    The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia.
    Blood. 2016 Apr 11. pii: blood-2016-03-643544.
    PubMed     Text format     Abstract available


  170. BAZARBACHI A
    Tax fingerprint in adult T-cell leukemia.
    Blood. 2016;127:1737-8.
    PubMed     Text format    


  171. PARIKH SA, Strati P, Tsang M, West CP, et al
    Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.
    Blood. 2016;127:1752-60.
    PubMed     Text format     Abstract available


  172. GU S, Chan WW, Mohi G, Rosenbaum J, et al
    Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.
    Blood. 2016;127:1803-13.
    PubMed     Text format     Abstract available


    March 2016

  173. Frei E III, Holland JF, Schneiderman MA, et al. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood. 1958;13(12):1126-1148.
    Blood. 2016;127:1621.
    PubMed     Text format    


  174. REDELL MS
    A STAT3 decoy lures AML out of hiding.
    Blood. 2016;127:1628-9.
    PubMed     Text format     Abstract available



  175. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609-630.
    Blood. 2016;127:1519.
    PubMed     Text format     Abstract available


  176. LUSKIN MR, Lee JW, Fernandez HF, Abdel-Wahab O, et al
    Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.
    Blood. 2016;127:1551-8.
    PubMed     Text format     Abstract available


  177. SCHULZE I, Rohde C, Scheller-Wendorff M, Baumer N, et al
    Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
    Blood. 2016;127:1575-86.
    PubMed     Text format     Abstract available


  178. STANLEY RF, Steidl U
    Ectopic DNMT3B expression delays leukemogenesis.
    Blood. 2016;127:1525-6.
    PubMed     Text format     Abstract available


  179. BABA T, Tanabe Y, Yoshikawa S, Yamanishi Y, et al
    MIP-1alpha/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
    Blood. 2016 Mar 22. pii: blood-2015-10-673087.
    PubMed     Text format     Abstract available


  180. WANG W, Cortes JE, Tang G, Khoury JD, et al
    Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
    Blood. 2016 Mar 22. pii: blood-2016-01-690230.
    PubMed     Text format     Abstract available


  181. WANQUET A, Birsen R, Lemal R, Hunault M, et al
    Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia.
    Blood. 2016 Mar 18. pii: blood-2016-02-697193.
    PubMed     Text format    


  182. KADIA TM
    Release the hounds: virotherapy with immunotherapy.
    Blood. 2016;127:1381-3.
    PubMed     Text format     Abstract available


  183. DUPLOYEZ N, Marceau-Renaut A, Boissel N, Petit A, et al
    Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Blood. 2016 Mar 15. pii: blood-2015-12-688705.
    PubMed     Text format     Abstract available


  184. NEESON P
    Allogeneic CAR19 cells clear ALL.
    Blood. 2016;127:1224-5.
    PubMed     Text format     Abstract available



  185. Rosenthal MC, Pisciotta AV, Komninos ZD, Goldenberg H, Dameshek W. The auto-immune hemolytic anemia of malignant lymphocytic disease. Blood. 1955;10(3):197-227.
    Blood. 2016;127:1217.
    PubMed     Text format    


  186. JACOBY E, Yang Y, Qin H, Chien CD, et al
    Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.
    Blood. 2016;127:1361-70.
    PubMed     Text format     Abstract available


  187. MAN N, Sun XJ, Tan Y, Garcia-Cao M, et al
    Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
    Blood. 2016 Mar 4. pii: blood-2015-11-677708.
    PubMed     Text format     Abstract available


  188. DIETRICH S, Pircher A, Endris V, Peyrade F, et al
    BRAF inhibition in hairy cell leukemia with low dose vemurafenib.
    Blood. 2016 Mar 3. pii: blood-2015-11-680074.
    PubMed     Text format     Abstract available


    February 2016
  189. OLOMBEL G, Guerin E, Guy J, Perrot JY, et al
    The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
    Blood. 2016 Feb 29. pii: blood-2016-01-689976.
    PubMed     Text format    


  190. CHEN Z, Hu S
    MYC/BCL2 double-hit lymphoma/leukemia mimicking acute leukemia at initial presentation.
    Blood. 2016;127:1072.
    PubMed     Text format    


  191. TAWANA K, Fitzgibbon J
    Inherited DDX41 mutations: 11 genes and counting.
    Blood. 2016;127:960-1.
    PubMed     Text format    


  192. BLACHLY JS
    Ribosomal revelation.
    Blood. 2016;127:958-9.
    PubMed     Text format    


  193. LEWINSOHN M, Brown AL, Weinel LM, Phung C, et al
    Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Blood. 2016;127:1017-23.
    PubMed     Text format     Abstract available


  194. MARCUCCI G, Li L
    Not only TKI! Targeting FLT3-ITD by autophagy.
    Blood. 2016;127:796-7.
    PubMed     Text format    


  195. WONG TN, Miller CA, Klco JM, Petti A, et al
    Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
    Blood. 2016;127:893-7.
    PubMed     Text format     Abstract available


  196. LARRUE C, Saland E, Boutzen H, Vergez F, et al
    Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.
    Blood. 2016;127:882-92.
    PubMed     Text format     Abstract available


  197. TEIRA P, Battiwalla M, Ramanathan M, Barrett AJ, et al
    Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
    Blood. 2016 Feb 16. pii: blood-2015-11-679639.
    PubMed     Text format     Abstract available


  198. DEININGER MW, Hodgson JG, Shah NP, Cortes JE, et al
    Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.
    Blood. 2016;127:703-12.
    PubMed     Text format     Abstract available


  199. SAGLIO G, Fava C
    BCR-ABL1 mutation not equal ponatinib resistance.
    Blood. 2016;127:666-7.
    PubMed     Text format    


  200. MARTINEZ-TRILLOS A, Navarro A, Aymerich M, Delgado J, et al
    Clinical impact of MYD88 mutations in chronic lymphocytic leukemia.
    Blood. 2016 Feb 4. pii: blood-2015-10-678490.
    PubMed     Text format    


  201. ISHIKAWA S
    Opposite RHOA functions within the ATLL category.
    Blood. 2016;127:524-5.
    PubMed     Text format     Abstract available


  202. NADEU F, Delgado J, Royo C, Baumann T, et al
    Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia.
    Blood. 2016 Feb 2. pii: blood-2015-07-659144.
    PubMed     Text format     Abstract available


  203. PABST C, Bergeron A, Lavallee VP, Yeh J, et al
    GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.
    Blood. 2016 Feb 1. pii: blood-2015-11-683649.
    PubMed     Text format     Abstract available


    January 2016
  204. VALSECCHI R, Coltella N, Belloni D, Ponente M, et al
    HIF-1alpha regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.
    Blood. 2016 Jan 29. pii: blood-2015-07-657056.
    PubMed     Text format     Abstract available


  205. PAGGETTI J, Moussay E
    BCR engagement in CLL: when translation goes wrong.
    Blood. 2016;127:378-80.
    PubMed     Text format     Abstract available


  206. MAUS MV
    Innate immune signaling in CLL.
    Blood. 2016;127:376-8.
    PubMed     Text format     Abstract available


  207. WALTER HS, Rule SA, Dyer MJ, Karlin L, et al
    A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
    Blood. 2016;127:411-9.
    PubMed     Text format     Abstract available


  208. WAGNER M, Oelsner M, Moore A, Gotte F, et al
    Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Blood. 2016;127:436-48.
    PubMed     Text format     Abstract available


  209. BELLON M, Lu L, Nicot C
    Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.
    Blood. 2016 Jan 26. pii: blood-2015-11-685032.
    PubMed     Text format     Abstract available


  210. FRAIETTA JA, Beckwith KA, Patel PR, Ruella M, et al
    Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
    Blood. 2016 Jan 26. pii: blood-2015-11-679134.
    PubMed     Text format     Abstract available


  211. ZHANG Q, Hossain DM, Duttagupta P, Moreira D, et al
    Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
    Blood. 2016 Jan 21. pii: blood-2015-08-665604.
    PubMed     Text format     Abstract available



  212. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949;4(2):160-167.
    Blood. 2016;127:271.
    PubMed     Text format    


  213. AWAN FT
    Cure for CLL?
    Blood. 2016;127:274.
    PubMed     Text format    


  214. THOMPSON PA, Wierda WG
    Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.
    Blood. 2016;127:279-86.
    PubMed     Text format     Abstract available


  215. LIBURA M, Giebel S, Piatkowska-Jakubas B, Pawelczyk M, et al
    Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
    Blood. 2016;127:360-2.
    PubMed     Text format    


  216. FUJIKAWA D, Nakagawa S, Hori M, Kurokawa N, et al
    Polycomb-dependent epigenetic landscape in adult T-cell leukemia.
    Blood. 2016 Jan 15. pii: blood-2015-08-662593.
    PubMed     Text format     Abstract available


  217. MINUCCI S
    DNA binding modes of leukemia oncoproteins.
    Blood. 2016;127:177-8.
    PubMed     Text format    


  218. ARNOUX I, Loosveld M
    Hepatosplenic T-cell lymphoma: an acute leukemia presentation.
    Blood. 2016;127:269.
    PubMed     Text format    


  219. WOYACH JA
    FCR holds up to the test of time: CLL8 follow-up.
    Blood. 2016;127:172-3.
    PubMed     Text format    


  220. LIU J, Zhu HH, Jiang H, Jiang Q, et al
    Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.
    Blood. 2016;127:243-50.
    PubMed     Text format     Abstract available


  221. FISCHER K, Bahlo J, Fink AM, Goede V, et al
    Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
    Blood. 2016;127:208-15.
    PubMed     Text format     Abstract available


  222. MIRANTES C, Dosil MA, Hills D, Yang J, et al
    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies.
    Blood. 2016 Jan 14. pii: blood-2015-09-669036.
    PubMed     Text format     Abstract available


  223. JAIN N, Lamb AE, O'Brien S, Ravandi F, et al
    Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Blood. 2016 Jan 8. pii: blood-2015-08-661702.
    PubMed     Text format     Abstract available


  224. BURGER JA
    Obinutuzumab: the more the merrier?
    Blood. 2016;127:6-8.
    PubMed     Text format     Abstract available


  225. STEIN EM, Tallman MS
    Emerging therapeutic drugs for AML.
    Blood. 2016;127:71-8.
    PubMed     Text format     Abstract available


  226. AL-HUSSAINI M, Rettig MP, Ritchey JK, Karpova D, et al
    Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.
    Blood. 2016;127:122-31.
    PubMed     Text format     Abstract available


  227. JAIN P, Kantarjian H, Patel KP, Nogueras Gonzalez G, et al
    Impact of BCR-ABL transcript type on response and survival in patients with chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
    Blood. 2016 Jan 4. pii: blood-2015-10-674242.
    PubMed     Text format     Abstract available


    December 2015
  228. HELSMOORTEL HH, Bresolin S, Lammens T, Cave H, et al
    LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia.
    Blood. 2015 Dec 28. pii: blood-2015-09-667808.
    PubMed     Text format     Abstract available


  229. SHEN W, Patnaik MM, Ruiz A, Russell SJ, et al
    Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.
    Blood. 2015 Dec 28. pii: blood-2015-06-652503.
    PubMed     Text format     Abstract available


  230. ISLAM P, Daniel C, Strelec L, Kaye AH, et al
    Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia.
    Blood. 2015 Dec 23. pii: blood-2015-12-686873.
    PubMed     Text format    


  231. LJUNGSTROM V, Cortese D, Young E, Pandzic T, et al
    Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
    Blood. 2015 Dec 16. pii: blood-2015-10-674572.
    PubMed     Text format     Abstract available


  232. WOUTERS BJ, Delwel R
    Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
    Blood. 2015 Dec 10. pii: blood-2015-07-604512.
    PubMed     Text format     Abstract available


  233. GRIMWADE D, Ivey A, Huntly BJ
    Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
    Blood. 2015 Dec 10. pii: blood-2015-07-604496.
    PubMed     Text format     Abstract available


  234. LOWENBERG B, Rowe JM
    Introduction to the Review Series on Advances in Acute Myeloid Leukemia (AML).
    Blood. 2015 Dec 10. pii: blood-2015-10-662684.
    PubMed     Text format    


  235. DOMBRET H, Gardin C
    An update of current treatments for adult acute myeloid leukemia.
    Blood. 2015 Dec 10. pii: blood-2015-08-604520.
    PubMed     Text format     Abstract available


  236. CORNELISSEN JJ, Blaise D
    Hematopoietic stem cell transplantation for patients with AML in first CR.
    Blood. 2015 Dec 10. pii: blood-2015-07-604546.
    PubMed     Text format     Abstract available


  237. UTTARKAR S, Dasse E, Coulibaly A, Steinmann S, et al
    Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Blood. 2015 Dec 2. pii: blood-2015-09-668632.
    PubMed     Text format     Abstract available


    November 2015
  238. KUCINE N, Marubayashi S, Bhagwat N, Papalexi E, et al
    Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
    Blood. 2015;126:2479-83.
    PubMed     Text format     Abstract available


  239. KAROL SE, Mattano LA Jr, Yang W, Maloney KW, et al
    Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Blood. 2015 Nov 20. pii: blood-2015-10-673848.
    PubMed     Text format     Abstract available


  240. LIU H, Sun X
    Pleomorphic plasma cell leukemia.
    Blood. 2015;126:2436.
    PubMed     Text format    


  241. LARSON RA
    Is there a best TKI for chronic phase CML?
    Blood. 2015;126:2370-5.
    PubMed     Text format     Abstract available


  242. STEENSMA DP
    Cytopenias + mutations - dysplasia = what?
    Blood. 2015;126:2349-51.
    PubMed     Text format    


  243. MATTHEWS GM, Mehdipour P, Cluse LA, Falkenberg KJ, et al
    Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.
    Blood. 2015;126:2392-403.
    PubMed     Text format     Abstract available


  244. CARGO CA, Rowbotham N, Evans PA, Barrans SL, et al
    Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.
    Blood. 2015;126:2362-5.
    PubMed     Text format     Abstract available


  245. VERHAGEN HJ, Smit MA, Rutten A, Denkers F, et al
    Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all trans retinoic acid.
    Blood. 2015 Nov 18. pii: blood-2015-07-653840.
    PubMed     Text format     Abstract available


  246. OROZCO JJ, Kenoyer A, Balkin ER, Gooley TA, et al
    Anti-CD45 radioimmunotherapy without TBI before BMT facilitates persistent haploidentical donor engraftment in a murine model.
    Blood. 2015 Nov 17. pii: blood-2014-12-617019.
    PubMed     Text format     Abstract available


  247. NAGATA Y, Kontani K, Enami T, Kataoka K, et al
    Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
    Blood. 2015 Nov 16. pii: blood-2015-06-644948.
    PubMed     Text format     Abstract available


  248. KWOK M, Davies N, Agathanggelou A, Smith E, et al
    ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells.
    Blood. 2015 Nov 12. pii: blood-2015-05-644872.
    PubMed     Text format     Abstract available


  249. ARANGO M
    Adult T-cell leukemia/lymphoma.
    Blood. 2015;126:2343.
    PubMed     Text format    


  250. BOSCH F, Abrisqueta P
    Ibrutinib in CLL: 2 sides of the same coin.
    Blood. 2015;126:2173-4.
    PubMed     Text format    


    October 2015
  251. ZENZ T, Huber W
    Mutational landscape and complexity in CLL.
    Blood. 2015;126:2078-9.
    PubMed     Text format    


  252. GUIEZE R, Robbe P, Clifford R, de Guibert S, et al
    Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
    Blood. 2015;126:2110-7.
    PubMed     Text format     Abstract available


  253. LANDGREN O
    No CLL transmission through blood transfusion.
    Blood. 2015;126:1978-9.
    PubMed     Text format     Abstract available


  254. LI Z, Chen P, Su R, Li Y, et al
    Overexpression and knockout of miR-126 both promote leukemogenesis.
    Blood. 2015;126:2005-15.
    PubMed     Text format     Abstract available


  255. SCHMID C, Labopin M, Socie G, Daguindau E, et al
    Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.
    Blood. 2015;126:2062-9.
    PubMed     Text format     Abstract available


  256. DEBORD C, Eveillard M
    Leukemic phase of a large B-cell lymphoma arising in KSHV-associated multicentric Castleman disease.
    Blood. 2015;126:1966.
    PubMed     Text format    


  257. EVEILLARD M, Moreau P
    Atypical plasma cell leukemia mistaken for lymphocytosis on blood count.
    Blood. 2015;126:1965.
    PubMed     Text format    


  258. SAMUDIO I, Konopleva M
    Targeting leukemia's "fatty tooth".
    Blood. 2015;126:1874-5.
    PubMed     Text format     Abstract available


  259. DEARDEN C
    So FCR, so good.
    Blood. 2015;126:1872-4.
    PubMed     Text format     Abstract available


  260. GAYNON PS
    ALL and osteonecrosis.
    Blood. 2015;126:1734-5.
    PubMed     Text format     Abstract available


  261. HWANG IS, Shin S, Min YH, Lee ST, et al
    NOTCH2 missplicing can occur in relation to apoptosis.
    Blood. 2015;126:1731-2.
    PubMed     Text format    


  262. PLESA A, Sujobert P
    This is not an erythroblast.
    Blood. 2015;126:1729.
    PubMed     Text format    


    September 2015
  263. OSHIMA M, Iwama A
    Nuclear, not cytoplasmic, PKR maneuvers in AML.
    Blood. 2015;126:1523-4.
    PubMed     Text format     Abstract available


  264. SPERLAZZA J, Rahmani M, Beckta J, Aust M, et al
    Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
    Blood. 2015;126:1462-72.
    PubMed     Text format     Abstract available


  265. ORTUNO FJ, Sola M
    Extreme dyserythropoiesis in the setting of acute erythroid leukemia.
    Blood. 2015;126:1391.
    PubMed     Text format    


  266. EMADI A
    Exploiting AML vulnerability: glutamine dependency.
    Blood. 2015;126:1269-70.
    PubMed     Text format    


  267. CALIGARIS-CAPPIO F
    Directing CLL-cell traffic.
    Blood. 2015;126:1267-8.
    PubMed     Text format    


  268. SERODY J
    GVHD and miR: good things in small packages.
    Blood. 2015;126:1265-7.
    PubMed     Text format    


  269. MUKHERJEE S
    "Blood feuds".
    Blood. 2015;126:1264-5.
    PubMed     Text format    


  270. OCHODNICKA-MACKOVICOVA K, Bahjat M, Bloedjes TA, Maas C, et al
    NF-kappaB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.
    Blood. 2015;126:1324-35.
    PubMed     Text format     Abstract available


    August 2015
  271. APOLLONIO B, Ramsay AG
    Exosomes and CAFs: partners in crime.
    Blood. 2015;126:1053-5.
    PubMed     Text format     Abstract available


  272. MAHIEUX R
    A vaccine against HTLV-1 HBZ makes sense.
    Blood. 2015;126:1052-3.
    PubMed     Text format     Abstract available


  273. SUGATA K, Yasunaga J, Mitobe Y, Miura M, et al
    Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
    Blood. 2015;126:1095-105.
    PubMed     Text format     Abstract available


    July 2015
  274. CHENG H, Hao S, Liu Y, Pang Y, et al
    Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation.
    Blood. 2015 Jul 17. pii: blood-2015-01-623645.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: